[1]
Burle, E. et al. 2026. Reconsidering Efficacy and Safety: A Critical Appraisal of Repurposing Anti-inflammatory Targeted Drugs in Darier disease. Acta Dermato-Venereologica. 106, (Apr. 2026), adv–2026. DOI:https://doi.org/10.2340/actadv.v106.adv-2026-0322.